SCS wins media patent
Thursday, 10 July, 2008
Stem Cell Sciences [ASX: STC] has been granted a UK Patent Office patent for the company's new range of stem cell culture media.
The patent covers the company's Culticell iSTEM range, which contains a combination of enzyme inhibitors. The range is based on technology described in Nature recently by stem cell research pioneer Professor Austin Smith, now at Cambridge University, who is chair of the company's scientific advisory board.
Smith discovered that with the inhibition of key enzymes in specific combinations it is possible to produce pluripotent stem cells without feeder cells, growth factors, leukaemia inhibitory factor or serum.
The patent covers every use of the media, including use of the media for cultivating stem cells.
Overuse of inhalers can increase heart attack risk
Overuse of reliever inhalers is associated with higher risks of developing and dying from...
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
